160 related articles for article (PubMed ID: 29417588)
21. The role of elective para-aortic lymph node irradiation in patients with locally advanced cervical cancer.
Yap ML; Cuartero J; Yan J; Pintilie M; Fyles A; Levin W; Manchul L; Milosevic M
Clin Oncol (R Coll Radiol); 2014 Dec; 26(12):797-803. PubMed ID: 25194726
[TBL] [Abstract][Full Text] [Related]
22. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Morris M; Eifel PJ; Lu J; Grigsby PW; Levenback C; Stevens RE; Rotman M; Gershenson DM; Mutch DG
N Engl J Med; 1999 Apr; 340(15):1137-43. PubMed ID: 10202164
[TBL] [Abstract][Full Text] [Related]
23. A retrospective review of 15 years of radical radiotherapy with or without concurrent cisplatin and/or 5-fluorouracil for the treatment of locally advanced cervical cancer.
Borowsky ME; Elliott KS; Pezzullo JC; Santoso P; Choi W; Choi K; Abulafia O
Bull Cancer; 2005 Feb; 92(2):E19-24. PubMed ID: 15749639
[TBL] [Abstract][Full Text] [Related]
24. Impact of CXCR4/CXCL12 Blockade on Normal Plasma Cells In Vivo.
Moore N; Moreno Gonzales M; Bonner K; Smith B; Park W; Stegall M
Am J Transplant; 2017 Jun; 17(6):1663-1669. PubMed ID: 28235241
[TBL] [Abstract][Full Text] [Related]
25. Randomized clinical trial of weekly versus triweekly cisplatin-based chemotherapy concurrent with radiotherapy in treatment of locally advanced cervical cancer: in regard to Ryu et al. (Int J Radiat Oncol Biol Phys 2011;81:e577-e581).
Chakraborty S; Patil N
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1320-1. PubMed ID: 22385716
[No Abstract] [Full Text] [Related]
26. Effect of cisplatin on the clinically relevant radiosensitivity of human cervical carcinoma cell lines.
Britten RA; Evans AJ; Allalunis-Turner MJ; Pearcey RG
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):367-74. PubMed ID: 8567337
[TBL] [Abstract][Full Text] [Related]
27. Hedgehog inhibition enhances efficacy of radiation and cisplatin in orthotopic cervical cancer xenografts.
Chaudary N; Pintilie M; Hedley D; Hill RP; Milosevic M; Mackay H
Br J Cancer; 2017 Jan; 116(1):50-57. PubMed ID: 27875522
[TBL] [Abstract][Full Text] [Related]
28. Randomized clinical trial of weekly vs. triweekly cisplatin-based chemotherapy concurrent with radiotherapy in the treatment of locally advanced cervical cancer: in regard to Sang-Young Ryu et al. (Int J Radiat Oncol Biol Phys 2011;81:e577-e581).
Goel S; Mitra S; Rawat S; Sharma SK; Sharma MK; Bhutani R; Kakria A
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1320. PubMed ID: 22385715
[No Abstract] [Full Text] [Related]
29. Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery +/- intraoperative electron beam radiotherapy in locally advanced cervical cancer.
Jurado M; Martínez-Monge R; García-Foncillas J; Azinovic I; Aristu J; López-García G; Brugarolas A
Gynecol Oncol; 1999 Jul; 74(1):30-7. PubMed ID: 10385548
[TBL] [Abstract][Full Text] [Related]
30. CXCR4 as biomarker for radioresistant cancer stem cells.
Trautmann F; Cojoc M; Kurth I; Melin N; Bouchez LC; Dubrovska A; Peitzsch C
Int J Radiat Biol; 2014 Aug; 90(8):687-99. PubMed ID: 24650104
[TBL] [Abstract][Full Text] [Related]
31. Study on CXCR4/SDF-1alpha axis in lymph node metastasis of cervical squamous cell carcinoma.
Zhang JP; Lu WG; Ye F; Chen HZ; Zhou CY; Xie X
Int J Gynecol Cancer; 2007; 17(2):478-83. PubMed ID: 17362322
[TBL] [Abstract][Full Text] [Related]
32. Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution.
Parker K; Gallop-Evans E; Hanna L; Adams M
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):140-6. PubMed ID: 18922646
[TBL] [Abstract][Full Text] [Related]
33. Baohuoside I suppresses invasion of cervical and breast cancer cells through the downregulation of CXCR4 chemokine receptor expression.
Kim B; Park B
Biochemistry; 2014 Dec; 53(48):7562-9. PubMed ID: 25407882
[TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non-small cell lung cancer.
Fahham D; Weiss ID; Abraham M; Beider K; Hanna W; Shlomai Z; Eizenberg O; Zamir G; Izhar U; Shapira OM; Peled A; Wald O
J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1167-1175.e1. PubMed ID: 22925564
[TBL] [Abstract][Full Text] [Related]
35. Simultaneous radiochemotherapy in cervical cancer: recommendations for chemotherapy.
Dunst J; Haensgen G
Strahlenther Onkol; 2001 Dec; 177(12):635-40. PubMed ID: 11789401
[TBL] [Abstract][Full Text] [Related]
36. Onbaekwon Suppresses Colon Cancer Cell Invasion by Inhibiting Expression of the CXC Chemokine Receptor 4.
Kim B; Yoon J; Yoon SW; Park B
Integr Cancer Ther; 2017 Jun; 16(2):244-251. PubMed ID: 27160279
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients.
Chen MF; Tseng CJ; Tseng CC; Yu CY; Wu CT; Chen WC
Cancer J; 2008; 14(3):200-6. PubMed ID: 18536561
[TBL] [Abstract][Full Text] [Related]
38. CXCL12 modulates the radiosensitivity of cervical cancer by regulating CD44.
Fu Z; Zhang P; Luo H; Huang H; Wang F
Mol Med Rep; 2018 Dec; 18(6):5101-5108. PubMed ID: 30320394
[TBL] [Abstract][Full Text] [Related]
39. Phenotypic knockout of CXCR4 by a novel recombinant protein TAT/54R/KDEL inhibits tumors metastasis.
Ma WF; Du J; Fu LP; Fang R; Chen HY; Cai SH
Mol Cancer Res; 2009 Oct; 7(10):1613-21. PubMed ID: 19825996
[TBL] [Abstract][Full Text] [Related]
40. Enhanced radiosensitization with interferon-alpha-2b and cisplatin in the treatment of locally advanced cervical carcinoma.
Stock RG; Dottino P; Jennings TS; Terk M; DeWyngaert JK; Beddoe AM; Cohen C
Gynecol Oncol; 1997 Dec; 67(3):309-15. PubMed ID: 9441780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
